Christoph Schimmelpfennig

Prognostic value of end-of-induction PET response after first-line immunochemotherapy for follicular lymphoma (GALLIUM): secondary analysis of a randomised, phase 3 trial

Judith Trotman, Sally F. Barrington, David Belada et al. · The Lancet Oncology · 2018 · 159 citations · Full text

Medicine, Immunology, Oncology +13

Ex Vivo Expanded Dendritic Cells Home to T-Cell Zones of Lymphoid Organs and Survive in Vivo after Allogeneic Bone Marrow Transplantation

Christoph Schimmelpfennig, Stephan Schulz, Caroline Arber et al. · American Journal Of Pathology · 2005 · 40 citations · Full text

Life Sciences, Cell Biology, Immunology +15

A real-time PCR assay for the differentiation of Candida species

Stephan Fricke, Christian Fricke, Christoph Schimmelpfennig et al. · Journal of Applied Microbiology · 2010 · 35 citations

Life Sciences, Microbiology, Molecular Biology +15

Skin involvement as the first manifestation of systemic aspergillosis in patients after allogeneic hematopoietic cell transplantation

Christoph Schimmelpfennig, Ralph Naumann, Torsten Zuberbier et al. · Bone Marrow Transplantation · 2001 · 24 citations

Medicine, Dermatology, Infectious Diseases +15

Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias

Cornelia Brendel, Brigitte Mohr, Christoph Schimmelpfennig et al. · Leukemia · 1999 · 21 citations

Life Sciences, Hematology, Oncology +16